The Cognitive Resilience Study (CogRes)
Alzheimer Disease
About this trial
This is an interventional diagnostic trial for Alzheimer Disease
Eligibility Criteria
Inclusion Criteria:
- Able to walk 2 minutes without assistive device or assistance from another person
- Cognitive function within normal limits
Exclusion Criteria:
- Unable to undergo MRI
- Left handed
- Red/Green Color Blind
- Severe vision impairments
- Diagnosis of Alzheimer's Disease or other dementia/memory problem
Sites / Locations
- Duke University Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
Experimental
High Risk Alzheimer's Disease
Low Risk Alzheimer Disease
This group includes subjects with APOEe4 homozygotes, the genetic profile associated with the highest risk for late-onset AD and the next highest-risk group, APOE e3/e4 heterozygotes. To target the highest risk among the APOEe3/e4 heterozygotes in ADPR, the study team will consider TOMM40-'523 variant status. Although there is uncertainty about the independent role of TOMM40 in AD risk-stratification (especially across racial/ethnic groups), this study will use TOMM40-'523 to guide heterozygote selection based on findings that among e3/e4 heterozygotes, longer TOMM40-523 polyT sequences are associated with earlier age of onset for late-onset AD.
This group includes e2/e2 homozygotes (rare) and e2/e3 heterozygotes. the genetic profile associated with low risk for late-onset development of Alzheimer's disease.